The Afinion™ Lipid Panel test and the fully automated Afinion™ Analyzer, give you reliable results conveniently available when and where you need them. Patient consultations can be carried out with confidence.
Test for quantitative determination of Total Cholesterol, High-Density Lipoprotein (HDL) cholesterol, Low- Density Lipoprotein (LDL) cholesterol, Triglycerides (Trig), non-HDL and Chol/HDL ratio in whole blood, serum and plasma to be used in the diagnosis and treatment of lipid disorders.
Test for the quantitative determination of:
Elevated cholesterol is one of the major risk factors for coronary heart disease, heart attack and stroke. As the blood cholesterol rises, so does the cardiovascular disease risk. Many patients such as those with metabolic syndrome have comorbid conditions such as high lipids and diabetes. And if other risk factors are present such as smoking, high blood pressure or diabetes, the risk increases even further.
Measuring a Lipid Panel/Cholesterol is recommended by NCEP (National Cholesterol Education Program) every five years in healthy adults, more regularly if you have other risk factors, in children and youths who are at an increased risk and to evaluate the success of lipid-lowering treatment.
| Afinion™ System Test | Code |
|---|---|
| Afinion™ Lipid Panel | 1116801 Global |
| 1116802 Nordic | |
| 1116799 Japan | |
| 1116803 India | |
| Afinion™ Lipid Panel Control | 1116800 Global |
Based on your current location, the content on this page may not be relevant for your country.
